Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does RPLND improve outcomes in men with intermediate-risk and high-risk germ cell tumors?

Nature Clinical Practice Urology volume 4, pages 654–655 (2007)Cite this article

boxed-textShayegan B et al. (2007) Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumor. BJU Int 99: 993–997

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Vergouwe Y et al. (2003) External validity of a prediction rule for residual mass histology in testicular cancer: an evaluation for good prognosis patients. Br J Cancer 88: 843–847

    Article  CAS  Google Scholar 

  2. Debono DJ et al. (1997) Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol 15: 1455–1464

    Article  CAS  Google Scholar 

  3. Steyerberg EW et al. (1999) Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis. Cancer 85: 1331–1341

    Article  CAS  Google Scholar 

  4. Fosså SD et al. (1989) Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer. J Urol 141: 557–559

    Article  Google Scholar 

  5. Oldenburg J et al. (2003) Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 21: 3310–3317

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Urology, Box 356510, 1959 NE Pacific Street, University of Washington, Seattle, WA 98195, USA dlin@u.washington.edu

Authors and Affiliations

  1. DW Lin is Assistant Professor at the Department of Urology, University of Washington, Seattle, WA, USA.,

    Daniel W Lin

Authors
  1. Daniel W Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, D. Does RPLND improve outcomes in men with intermediate-risk and high-risk germ cell tumors?. Nat Rev Urol 4, 654–655 (2007). https://doi.org/10.1038/ncpuro0966

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0966

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing